Heartflow (NASDAQ:HTFL) CEO John C.M. Farquhar Sells 38,900 Shares of Company Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John Farquhar sold 38,900 shares of the company’s stock in a transaction on Monday, October 12th. The shares were sold at an average price of $49.57, for a total value of $1,928,273.00. Following the transaction, the chief executive officer directly owned 283,014 shares in the company, valued at $14,029,003.98. This trade represents a 12.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Friday, September 11th, John Farquhar sold 3,890 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total transaction of $194,500.00.
• On Thursday, September 10th, John Farquhar sold 35,010 shares of Heartflow stock. The shares were sold at an average price of $46.42, for a total transaction of $1,625,164.20.
• On Friday, August 21st, John Farquhar sold 27,230 shares of Heartflow stock. The shares were sold at an average price of $50.00, for a total transaction of $1,361,500.00.
• On Tuesday, August 18th, John Farquhar sold 32,676 shares of Heartflow stock. The stock was sold at an average price of $45.00, for a total transaction of $1,470,420.00.
• On Friday, August 14th, John Farquhar sold 15,560 shares of Heartflow stock. The shares were sold at an average price of $39.06, for a total transaction of $607,773.60.
• On Monday, August 10th, John Farquhar sold 22,562 shares of Heartflow stock. The shares were sold at an average price of $28.31, for a total value of $638,730.22.

Heartflow Price Performance

NASDAQ:HTFL opened at $49.46 on Thursday. Heartflow, Inc. has a 1-year low of $20.13 and a 1-year high of $54.32. The business’s 50-day moving average price is $46.40 and its two-hundred day moving average price is $34.99.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The business had revenue of $64.08 million for the quarter. The company’s revenue for the quarter was up 47.7% on a year-over-year basis. Analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Institutional Investors Weigh In On Heartflow

Several large investors have recently made changes to their positions in HTFL. GAMMA Investing LLC grew its holdings in shares of Heartflow by 75.1% during the third quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock worth $32,000 after buying an additional 275 shares in the last quarter. TrueMark Investments LLC raised its position in Heartflow by 1.4% in the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after buying an additional 379 shares during the last quarter. Strs Ohio lifted its stake in Heartflow by 35.3% in the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after acquiring an additional 1,200 shares in the last quarter. Integrated Wealth Concepts LLC bought a new stake in Heartflow in the 2nd quarter valued at approximately $53,000. Finally, Mayport LLC boosted its position in Heartflow by 20.0% during the 2nd quarter. Mayport LLC now owns 12,000 shares of the company’s stock worth $352,000 after acquiring an additional 2,000 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts have weighed in on HTFL shares. JPMorgan Chase & Co. increased their target price on shares of Heartflow from $35.00 to $45.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a report on Tuesday, June 30th. Morgan Stanley upped their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an “equal weight” rating in a research report on Friday, August 14th. Wall Street Zen upgraded shares of Heartflow from a “hold” rating to a “buy” rating in a research report on Saturday, October 3rd. Finally, Canaccord Genuity Group raised their price objective on Heartflow from $45.00 to $56.00 and gave the stock a “buy” rating in a research note on Tuesday, September 22nd. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $46.25.

About Heartflow

HeartFlow, Inc is a medical technology company focused on improving the diagnosis and management of coronary artery disease. The company develops software and clinical tools that use artificial intelligence, advanced image analysis and data from coronary computed tomography angiography (CCTA) scans to provide noninvasive assessments of blood flow and potential blockages in the heart.

Its principal product is the HeartFlow Analysis, which creates a personalized, three-dimensional model of a patient’s coronary arteries and can estimate the impact of blockages on blood flow.